CAMP4 TherapeuticsCAMP
13F holders, Q3 2025 (September 30)29holders
8new positions
8sold out
1famous investor
$3.00avg. 13F price*
At the end of Q3 2025, 29 institutions reported holding CAMP4 Therapeutics Corp. (CAMP) in their 13F filings, unchanged from Q2 2025. 8 opened new positions and 8 sold out. The largest holders were 5AM Venture Management, LLC ($17.6M), Janus Henderson Group PLC ($13.9M) and Vivo Capital, LLC ($11.8M). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- CAMP4 Therapeutics Corp.
- CUSIP
- 13463J101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $34.0M |
| Exits | 8 | $100K |
All 13F filers, Q2 2025 → Q3 2025: 16,678,093 shares bought and 212,625 shares sold, net +16,465,468 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 29 holders
| 5AM Venture Management, LLC | 6.45% | Add +100.5% | 5,869,091 | $17.6M |
| Janus Henderson Group PLC | 0.01% | New | 4,640,970 | $13.9M |
| Vivo Capital, LLC | 0.95% | New | 3,921,568 | $11.8M |
| Enavate Sciences Gp, LLC | 3.47% | No change | 3,785,802 | $11.4M |
| FMR LLC | 0.00% | Add +397.3% | 3,023,434 | $9.1M |
| a16z Capital Management, L.L.C. | 0.46% | No change | 2,125,339 | $6.4M |
| Adage Capital Partners Gp, L.L.C. | 0.01% | New | 1,960,784 | $5.9M |
| HarbourVest Partners LLC | 1.86% | No change | 1,271,948 | $3.8M |
| Silverarc Capital Management, LLC | 0.28% | New | 653,594 | $2.0M |
| Vanguard Group Inc. | 0.00% | Reduce -4.7% | 313,506 | $941K |
| Alyeska Investment Group, L.P. | 0.00% | No change | 200,000 | $600K |
| Two Sigma Investments, LP | 0.00% | New | 97,371 | $292K |
| Millennium Management | 0.00% | Reduce -28.5% | 95,071 | $285K |
| Victory Capital Management Inc. | 0.00% | Reduce -0.3% | 82,790 | $248K |
| Geode Capital Management, LLC | 0.00% | Reduce -19.7% | 60,371 | $181K |
| State Street Corp. | 0.00% | New | 26,000 | $78K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 25,000 | $75K |
| Mariner, LLC | 0.00% | New | 17,298 | $52K |
| Northern Trust Corp. | 0.00% | No change | 14,615 | $44K |
| BlackRock, Inc. | 0.00% | Reduce -86.4% | 11,437 | $34K |
| UBS Group AG | 0.00% | Add +38.4% | 7,043 | $21K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +47.5% | 5,649 | $17K |
| Royal Bank of Canada | 0.00% | No change | 953 | $3K |
| Bank of America Corp. | 0.00% | Reduce -56.6% | 283 | $849 |
| BNP Paribas Financial Markets | 0.00% | Reduce -81.7% | 78 | $234 |
| Barclays PLC | 0.00% | New | 70 | $210 |
| SBI Securities Co., Ltd. | 0.00% | Reduce -25.0% | 15 | $45 |
| Morgan Stanley | 0.00% | Reduce -99.8% | 3 | $9 |
| Cwm, LLC | 0.00% | Reduce -92.7% | 5 | $0 |
"% of holder's portfolio" is CAMP's weight in each manager's 13F, not the share of CAMP4 Therapeutics Corp. the manager owns.